The expression of EGFLAM-AS1 in leiomyomas was upregulated; EGFLAM-AS1 is a tumor suppressor in many cancers through its targeting leukemia inhibitory factor receptor (LIFR) which is a known metastasis inhibitor [69]. Here, LIFR is linked to cancer.